Literature DB >> 48249

Antibodies reactive with cell surface carbohydrates.

B A Sela, J L Wang, G M Edelman.   

Abstract

Normal and immune sera from various animal species were fractionated on columns of Sepharose covalently coupled with the glycoprotein fetuin. Elution of the material bound to fetuin yielded low but reproducible amounts of protein, ranging from 0.02 to 0.2% of the protein mass of the input sera. This material has been identified by immunoelectrophoresis in agar and by zone electrophoresis on cellulose acetate as immunoglobulin. The Ig fractions bound and agglutinated erythrocytes of various species, and also bound to cells from various mouse tissues including heart, kidney, thymus, and spleen. In all cases, the binding was inhibited by glycoproteins such as fetuin and thyroglobulin, by a glycopeptide isolated from fetuin, and by some bacterial lipopolysaccharides. When the binding of these Ig fractions to mouse splenocytes was tested in the presence of 17 saccharides, no inhibition of binding was observed except by sialic acid, D-galactose, N-acetyl-D-glucosamine, and D-mannose, all of which showed partial inhibition. Inasmuch as these four saccharides are present on the carbohydrate moiety of fetuin, the results suggest that the isolated material is a carbohydrate-specific Ig (CS-Ig) fraction of serum capable of binding to the carbohydrate portion of cell surface receptors and glycoproteins. When bound to lymphocytes, these CS-Ig molecules induced redistribution (patching and capping) of cell surface receptors. Moreover, the CS-Ig fractions from chicken and rabbit sera were weakly mitogenic for mouse splenic lymphocytes. CS-Ig fractions are useful new reagents for studying glycoproteins and the interactions and activities of cell surface carbohydrates.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 48249      PMCID: PMC432479          DOI: 10.1073/pnas.72.3.1127

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  The biochemistry of plant lectins (phytohemagglutinins).

Authors:  H Lis; N Sharon
Journal:  Annu Rev Biochem       Date:  1973       Impact factor: 23.643

2.  Restriction of the mobility of lymphocyte immunoglobulin receptors by concanavalin A.

Authors:  I Yahara; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

3.  Induction of lymphocyte transformation by sequential treatment with neuraminidase and galactose oxidase.

Authors:  A Novogrodsky; E Katchalski
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

4.  The structure of the glycopeptide of human gamma G myeloma proteins.

Authors:  R Kornfeld; J Keller; J Baenziger; S Kornfeld
Journal:  J Biol Chem       Date:  1971-05-25       Impact factor: 5.157

5.  A revised structure for the Forssman glycolipid hapten.

Authors:  B Siddiqui; S Hakomori
Journal:  J Biol Chem       Date:  1971-09-25       Impact factor: 5.157

6.  Carbohydrate inhibition studies of the naturally occurring human antibody to neuraminidase-treated human lymphocytes.

Authors:  G N Rogentine; B A Plocinik
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

7.  Concanavalin A derivatives with altered biological activities.

Authors:  G R Gunther; J L Wang; I Yahara; B A Cunningham; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

8.  Chemical nature of the receptor site for various phytomitogens.

Authors:  S Toyoshima; M Fukuda; T Osawa
Journal:  Biochemistry       Date:  1972-10-10       Impact factor: 3.162

9.  The covalent and three-dimensional structure of concanavalin A.

Authors:  G M Edelman; B A Cunningham; G N Reeke; J W Becker; M J Waxdal; J L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

10.  The kinetics of cellular commitment during stimulation of lymphocytes by lectins.

Authors:  G R Gunther; J L Wang; G M Edelman
Journal:  J Cell Biol       Date:  1974-08       Impact factor: 10.539

View more
  17 in total

1.  Modulation of lymphocyte receptor mobility by locally bound concanavalin A.

Authors:  I Yahara; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  The lymphocyte plasma membrane: locus of control in the immune response.

Authors:  L M Jerry; A K Sullivan
Journal:  In Vitro       Date:  1976-03

3.  Receptor diffusion on cell surfaces modulated by locally bound concanavalin A.

Authors:  J Schlessinger; E L Elson; W W Webb; I Yahara; U Rutishauser; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  Antibodies to human albumin epitopes in type 1 (insulin-dependent) diabetes mellitus.

Authors:  R Mangili; G C Viberti; D Vergani
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

5.  Comments on the paper by M.T.Zenzes and T.E.Reed: variability in the amount of serologically detectable H-Y antigen.

Authors:  A Mayerová; U Müller; U Wiberg; U Wolf; M Fraccaro
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  In vivo activity of asialo-erythropoietin in combination with asialo-glycoproteins.

Authors:  E Weiland; W Höppner; F Bläker; W Thorn
Journal:  Blut       Date:  1982-03

7.  Biological effects of antibodies to lymphocyte surface receptors.

Authors:  J W Goding
Journal:  Springer Semin Immunopathol       Date:  1982

8.  Studies of the human lymphocyte-mouse erythrocyte bond.

Authors:  P D Zalewski; I J Forbes
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

9.  Autoantibodies in systemic lupus erythematosus and normal subjects.

Authors:  E Pateraki; E Kaklamani; P Kaklamanis; R Portocalas; A Aessopos
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

10.  Rosette formation between human lymphocytes and sheep erythrocytes. Inhibition of rosette formation by specific glycopeptides.

Authors:  D H Boldt; J P Armstrong
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.